Full-Time

Digital Experience Designer

Cell Signaling Technology

Cell Signaling Technology

1,001-5,000 employees

Antibody development and validated research tools

Compensation Overview

$140k - $180k/yr

Peabody, MA, USA

In Person

Onsite at Danvers, MA facility.

Category
UI/UX & Design (1)
Required Skills
Interaction Design
UI/UX Design
Usability Testing/Engineering
Information Architecture
Graphic Design

Get referred to Cell Signaling Technology

See people who can refer or advise you

Requirements
  • Minimum of 5 years of demonstrable experience in UX/UI design for digital platforms, with a strong portfolio showcasing user-centered design solutions for complex websites utilizing an enterprise content management system. (CMS)
Responsibilities
  • Conduct thorough user research, including interviews and discovery work, to deeply understand the needs, pain points, and behaviors of scientists interacting with our digital platforms.
  • Analyze web analytics, user replay, and other relevant data to identify usability challenges, improvement areas, and optimization opportunities.
  • Enhance and evolve user personas, developing detailed user flows and scenarios based on the specific goals of each persona.
  • Partner with market research to plan and execute usability testing of prototypes and existing interfaces to evaluate design effectiveness.
  • Capture, synthesize, and translate user feedback and research insights into actionable design decisions and future iterations.
  • Design intuitive and aesthetically pleasing user interfaces that simplify complex scientific information and workflows, ensuring user-friendliness.
  • Rapidly create wireframes, mockups, and interactive prototypes to effectively communicate design concepts and facilitate iterative testing.
  • Enhance existing user flows and the overall information architecture of the website based on user research and best practices.
  • Utilize and evolve our existing design system with a focus on composable design, proposing new components and templates to ensure consistency and scalability within our enterprise CMS.
  • Provide fully annotated designs and templates for CMS development, partnering with IT to ensure alignment on design, interaction patterns, and expected behavior.
  • Collaborate effectively with cross-functional stakeholders, including marketing communications, market research, sales, product development, and external agencies, to align design solutions with business objectives.
  • Clearly communicate design rationale and research findings to diverse audiences.
  • Maintain a consistent user experience across all digital touchpoints by contributing to and adhering to brand guidelines and design templates.
  • Translate UX research insights into actionable design outcomes that drive measurable improvements.
  • Guide the planning, scaling, documentation, and execution of Human Factors and UI/UX design activities in alignment with regulatory and quality teams.
  • Own and deliver interaction and visual designs across multiple platforms (web, potentially mobile or other interfaces), from low-fidelity wireframes to high-fidelity prototypes, with an understanding of CMS implications. Integrate user feedback, research, and product metrics into all design decisions to create impactful and intuitive experiences.
  • Collaborate with the regulatory team to develop design strategies for new product submissions in accordance with relevant guidelines.
  • Contribute to the overall UX vision and strategy, building strong relationships to gain buy-in and operationalize the strategy across teams.
  • Maintain a strong understanding of current UX/UI design trends, best practices, and accessibility standards, and apply them appropriately to our products.
Desired Qualifications
  • Life sciences or biotech industry experience is a significant plus, demonstrating an understanding of the domain and its users.
  • Proven experience planning, conducting, and analyzing various user research methodologies (e.g., interviews, surveys, contextual inquiries) and usability testing sessions.
  • A strong understanding of current trends and best practices in UI/UX design, accessibility (WCAG guidelines), and emerging technologies.
  • Experience working in an Agile or Scrum development environment, with a demonstrated ability to iterate quickly based on feedback.
  • Familiarity with data visualization principles and the ability to present complex information in a clear and accessible manner for scientific users.
  • Experience with design for scientific or technical audiences, including understanding their specific needs and workflows.
  • A portfolio of case studies that showcase successful user-centered design solutions for web applications, ideally those with complex information architectures or scientific content.
  • Experience with A/B testing methodologies and analyzing results to inform design decisions.
  • Familiarity with Content Management Systems (CMS) and how design integrates with them.
Cell Signaling Technology

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Get referred to Cell Signaling Technology

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Quantum-Si and CST partnered June 2026 to validate PTM analysis on Proteus.
  • CST and MJFF are developing Parkinson's antibodies, expanding disease-targeted reagent demand.
  • Nordic Biosite began exclusive Nordic distribution for CST G4S Linker antibodies in August 2026.

What critics are saying

  • CST sells research-use-only reagents; a single validation miss destroys trust fast.
  • Spatial-biology rivals compress CST's mid-plex advantage as panels standardize.
  • If citation leadership fades, CST's antibody brand moat collapses and pricing power erodes.

What makes Cell Signaling Technology unique

  • CST remains scientist-owned and runs a 600-plus employee antibody platform from Danvers.
  • CiteAb named CST 2026 Phospho Antibody Supplier of the Year.
  • CST pairs validated antibodies with SignalStar multiplex IHC and PTM analysis partnerships.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Tuition Reimbursement

Unlimited Paid Time Off

Parental Leave

Employee Assistance Program

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

27%

1 year growth

27%

2 year growth

27%
Nordic Biosite
Aug 19th, 2026
Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies.

Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies. news August 19 2026 Nordic Biosite is excited to announce its exclusive distribution partnership across Sweden, Denmark, Norway, and Finland for Cell Signaling Technology's (CST) premier line of Pre-GMP-grade G4S Linker antibodies. Chimeric Antigen Receptor (CAR) cell therapy is moving at a rapid pace, but researchers often struggle with reliable tracking reagents during early-phase development. This exclusive partnership changes that by bringing CST's premier translational tools directly to the Nordic region. Nordic Biosite is fully authorized to distribute the following early-access, Pre-GMP-grade products: * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (PE Conjugate) * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (Biotin Conjugate) By keeping these high-demand reagents in local stock, Nordic Biosite eliminates long international shipping delays, ensuring your lab has immediate access to the exact tools you need to advance your cell therapy research. News & articles. News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026 News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.